• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

    6/18/24 8:30:00 AM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email

    Conference call to be on Tuesday, July 2, 2024, at 5 p.m. EDT

    Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), announced today that it will report third quarter fiscal 2024 financial results after the market close on Tuesday, July 2, 2024.

    Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.

    About Simulations Plus

    With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the Biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.

    Environmental, Social, and Governance (ESG)

    We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240618346263/en/

    Get the next $SLP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    10/26/2021$65.00 → $53.00Hold → Buy
    Craig Hallum
    7/13/2021$95.00 → $54.00Outperform
    Raymond James
    More analyst ratings

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Simulations Plus downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

      7/15/25 8:39:07 AM ET
      $SLP
      EDP Services
      Technology
    • Stephens initiated coverage on Simulations Plus with a new price target

      Stephens initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $39.00

      11/15/24 8:20:56 AM ET
      $SLP
      EDP Services
      Technology
    • KeyBanc Capital Markets initiated coverage on Simulations Plus with a new price target

      KeyBanc Capital Markets initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $47.00

      7/29/24 7:43:47 AM ET
      $SLP
      EDP Services
      Technology

    $SLP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Simulations Plus Inc.

      10-Q - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 8:02:18 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 7:56:13 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/14/25 4:49:27 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Simulations Plus Invests in Clinical Development Technology Company Nurocor

      Investment to accelerate innovations in biopharma development through Corporate Development Initiative Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to improve efficiency, reusability, governance, and automation for pharmaceutical companies through digitalization in the clinical development phase. Its solution significantly accelerates the typical clinical trial lif

      7/14/25 4:15:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

      Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O'Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices and Healthcare Services Forum taking place in Boston, Massachusetts. Mr. O'Connor will host one-on-one meetings with institutional investors on Tuesday, June 17, 2025. For more information about the events or questions about registration, interested parties should reach out to their contacts at Citizens. About Simulations Plus, Inc. With more

      6/12/25 7:50:00 AM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woltosz Walter S sold $366,623 worth of shares (20,000 units at $18.33), decreasing direct ownership by 0.60% to 3,304,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      7/2/25 4:24:37 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S sold $543,074 worth of shares (20,000 units at $27.15), decreasing direct ownership by 0.60% to 3,324,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      6/3/25 4:57:16 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S was granted 786 shares and sold $670,150 worth of shares (20,000 units at $33.51), decreasing direct ownership by 0.57% to 3,344,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      5/1/25 5:53:05 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    See more
    • QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

      QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

      6/12/24 8:58:00 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

      LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

      12/1/20 4:05:00 PM ET
      $DIS
      $SLP
      $F
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
      EDP Services
      Technology

    $SLP
    Financials

    Live finance-specific insights

    See more
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

      Updates fiscal 2025 revenue guidance range Third quarter fiscal 2025 full results to be released on July 2, 2025, with conference call at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 million and $20 million Full year fiscal 2025 revenue is expected to range between $76 millio

      6/11/25 4:30:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

      Total revenue grew 23% year-over-year driven by strong growth in both software and services Maintains full-year revenue guidance of $90 to $93 million and adjusted diluted EPS of $1.07 to $1.20 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025. Second Quarter 2025 Financial Highlights (as compared to second quarter 2024) Total revenue increased 23% to $22.4 million Software revenue increased 16% to $13.5 million, repres

      4/3/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      8/8/24 2:18:03 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/13/24 5:13:58 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/12/24 4:59:04 PM ET
      $SLP
      EDP Services
      Technology